Stock Price
1,520.60
Daily Change
18.95 1.26%
Monthly
11.18%
Yearly
26.08%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR51.23B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Cipla INR 39.1B 2.54B Mar/2026
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Dr.Reddys Laboratories INR 37.77B 13.6B Mar/2026
Hindustan Unilever INR 78.72B 2.41B Mar/2026
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
UPL INR 55.96B 1.01B Dec/2025